Related Experiment Video

Updated: Jul 19, 2025

Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics
04:01

Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics

Published on: March 15, 2024

1.0K

Targeting ferroptosis in renal cell carcinoma: Potential mechanisms and novel therapeutics

Lei Yang1, Yu Fan1, Qian Zhang1,2

  • 1Department of Urology, Peking University First Hospital, Institute of Urology, National Research Center for Genitourinary Oncology, Peking University, Beijing, China.

Heliyon
|August 9, 2023
PubMed

Insights

Renal cell carcinoma (RCC) is a growing cancer resistant to chemotherapy. Ferroptosis, an iron-dependent cell death, shows promise as a therapeutic target and clinical marker for RCC treatment.

Area of Science:

  • Oncology
  • Cell Biology
  • Biochemistry

Background:

  • Renal cell carcinoma (RCC) is a prevalent urologic malignancy with increasing incidence worldwide.
  • Advanced RCC exhibits resistance to conventional chemotherapy, necessitating novel therapeutic strategies.
  • Ferroptosis, a form of programmed cell death driven by iron-dependent lipid peroxidation, is implicated in tumor progression and drug resistance.

Purpose of the Study:

  • To review the regulatory mechanisms of ferroptosis concerning iron, amino acid, and lipid metabolism.
  • To elucidate the intricate relationship between ferroptosis and renal cell carcinoma (RCC).
  • To explore the potential of ferroptosis regulators as therapeutic targets and clinical markers for RCC.

Main Methods:

  • Literature review summarizing current research on ferroptosis and RCC.
  • Analysis of the roles of iron, amino acid, and lipid metabolism in ferroptosis.
  • Discussion of ferroptosis regulators' impact on RCC progression and chemoresistance.

Main Results:

  • Ferroptosis plays a significant role in RCC progression and chemoresistance.
  • Various ferroptosis regulators are dysregulated in RCC, exhibiting both tumor-suppressive and oncogenic effects.
  • These regulators present potential as clinical markers for RCC prognosis.

Conclusions:

  • Targeting ferroptosis regulators could offer novel therapeutic strategies for advanced RCC.
  • Ferroptosis-related biomarkers may aid in predicting RCC patient outcomes.
  • Further research into ferroptosis mechanisms in RCC is warranted for clinical translation.
Keywords:
FerroptosisPrognosisProgressionRenal cell carcinomaTreatment

More Related Videos

Modeling Spontaneous Metastatic Renal Cell Carcinoma mRCC in Mice Following Nephrectomy11:27

Modeling Spontaneous Metastatic Renal Cell Carcinoma mRCC in Mice Following Nephrectomy

Published on: April 29, 2014

16.7K
A Syngeneic Mouse Model of Metastatic Renal Cell Carcinoma for Quantitative and Longitudinal Assessment of Preclinical Therapies06:38

A Syngeneic Mouse Model of Metastatic Renal Cell Carcinoma for Quantitative and Longitudinal Assessment of Preclinical Therapies

Published on: April 12, 2017

13.6K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.7K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.1K
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
2.5K